You are right, Bsav. Over the past few months, the basic financial data have changed for the better in a way that has taken most of us by surprise. The compounding pharmacy business is a sector that has offered Scrips a perfect fit with its business model, and CEO Bob Schneiderman was quick to recognize that opportunity and take it.